Design Therapeutics, Inc. DSGN Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Design Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: Design Therapeutics, Inc.’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Design Therapeutics, Inc.'s total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Design Therapeutics, Inc.'s total liabilities & equity?
- Design Therapeutics, Inc. (DSGN) reported total liabilities & equity of $230.44M in Q1 2026.
- How has Design Therapeutics, Inc.'s total liabilities & equity changed year-over-year?
- Design Therapeutics, Inc.'s total liabilities & equity decreased by 3.0% year-over-year, from $237.48M to $230.44M.
- What is the long-term trend for Design Therapeutics, Inc.'s total liabilities & equity?
- Over 5 years (2020 to 2025), Design Therapeutics, Inc.'s total liabilities & equity has grown at a 44.0% compound annual growth rate (CAGR), from $36.52M to $226.2M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.